+ Products Search
Please Enter Product Name Or CAS.NO
 
+ All Products
+ New Products
+ Hot Products
 
Home New Products
New Products

   CAS NO.    Products Name
   1005193-64-5 Trifluoromethyl Dechloro Ethylcloprostenolamide  more...
   (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide...
   1138395-12-6 N-Cyclopropyl Bimatoprost  more...
   Synonyms:(5Z)-N-Cyclopropyl-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenamide...
   404830-45-1 15-Keto Travoprost  more...
   Synonyms:(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid 1-Methylethyl Ester; 15-keto Fluprostenol Isopropyl Est...
   209860-89-9 Tafluprost ethyl ester  more...
   Analogs of prostaglandin F2α (PGF2α), which act primarily at the FP receptor, have been approved for the treatment of glaucoma.1,2,3,4 Tafluprost (free acid) (Item No. 10005439) is a PG...
   846557-71-9 ML385  more...
   ML385 interacts with NRF2 and affects the DNA binding activity of the NRF2-MAFG protein complex. The addition of ML385 decreases anisotropy in a dose-dependent manner, with an IC50 of 1...
   1527473-33-1 PF06447475 PF 06447475  more...
   PF-06447475 inhibits LRRK2 enzyme and LRRK2 in the whole cell assay with IC50s of 3 and 25 nM, respectively. Cells incubated with PF-06447475 alone (0.5, 1, 3 μM) or in the presence of ...
   1310726-60-3 Upadacitinib ABT494  more...
   Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor being developed for the treatment of several autoimmune disorders with an IC50 of 43 nM....
   439239-90-4 Lasmiditan  more...
   Lasmiditan (COL-144; LY573144) is a high-affinity, highly selective 5-HT1F receptor agonist(Ki=2.1 nM), compared with Ki of 1043 nM and 1357 nM at the 5-HT(1B) and 5-HT(1D) receptors, r...
   1025504-45-3 Valbenazine  more...
   Valbenazine is a prodrug of the (+)-α isomer of tetrabenazine for tardive syndrome therapy, and inhibits VMAT2 function....
   865305-30-2 AF 353  more...
   AF-353 is a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist, inhibits human and rat P2X3 (pIC50= 8.0). IC50 value: pIC50 = 8.0 (pIC50, for P2X3) Target: P2X3/P2X2/...

Prev  1  2  3  ...  103  104  Next    

 
Latest Catalog
Main products
Contact Us
Tel: +86-576-88813233
Tel: +86-576-88205808
Fax: +86-576-88229589
Sales Department:
sales@pharm-intermediates.com
crene.pharm@gmail.com
order@pharm-intermediates.com
Msn:
Skype: Call me!
yahoo:
Homepage | About Us | Products | News&Events | Custom Synthesis | Order Infomation | Contact Us
Friendly link: molbase    molbase    Copyright © Taizhou Crene Biotechnology Co.,Ltd.